Consequently, there were statistically significant differences in age, BMI, diabetes, metabolic syndrome, ALT, AST, tumour size, secondary tumour, portal invasion, postoperative treatment and pathological grade (P < 0.05) between the first groups (B-AFP(+) vs. NBNC-AFP(-)). This evidence concerns the gene AFP and metabolic syndrome.